Join Drs. Leonidas Tapias and Michael Krainock as they review the latest clinical data supporting the use of ctDNA for molecular residual disease (MRD) assessment in resectable NSCLC. Learn how MRD helps identify NSCLC patients who remain at high recurrence risk after surgery and detects recurrence before radiographic imaging. The webinar will conclude with a review of real-world case studies, practical considerations for implementing MRD testing in routine practice, and future directions for research.  

Sponsored by Natera, Inc.

Date
8 p.m. ET

Return To Main Page

The Best Science Presented at 2025 ASCO

The STS 2025 Best of Lung Cancer Science special edition podcast series offers members direct access to the most relevant and practice-changing science in lung cancer, curated and interpreted by thoracic surgeons for thoracic surgeons.

Return To Main Page

The Best Science Presented at the 2025 European Lung Cancer Conference 

The STS 2025 Best of Lung Cancer Science special edition podcast series offers members direct access to the most relevant and practice-changing science in lung cancer, curated and interpreted by thoracic surgeons for thoracic surgeons.

Return To Main Page

The Best Science Presented at the 2025 World Conference on Lung Cancer

The STS 2025 Best of Lung Cancer Science special edition podcast series offers members direct access to the most relevant and practice-changing science in lung cancer, curated and interpreted by thoracic surgeons for thoracic surgeons.

In this episode of Thinking Thoracic, host Dr. Erin Gillaspie talks with Dr. Robert Lentz and Dr. Fabien Maldonado about the groundbreaking VERITAS trial, which is reshaping how clinicians diagnose lung cancer. Published in the New England Journal of Medicine, the VERITAS trial compared navigational bronchoscopy with CT-guided biopsy in a rigorous, randomized design, bringing much-needed evidence to interventional pulmonology.

45 min.

The latest episode of Thinking Thoracic takes on a topic that’s often considered taboo: finances. Host Erin Gillaspie, MD, MPH, sits down with Lawrence Greiten, MD, and Josh Daily, MD, to discuss their recent paper examining financial decision-making in cardiothoracic surgery. From training pathways to compensation survey data, the conversation highlights how earnings and financial trade-offs shape career choices and negotiations. Tune in for practical insights every surgeon, especially those early in their careers, can use.

1 hr

This latest episode of Thinking Thoracic, an STS podcast, features host Erin Gillaspie, MD, in conversation with Jonathan Spicer, MD, a leading thoracic oncologist and clinical trial investigator. The two dive into the landmark CheckMate 816 trial, which helped usher in a new era for immunotherapy in lung cancer treatment. Dr. Spicer shares insights on trial design, clinical outcomes, and what these findings mean for the future of thoracic surgery and oncology. Listen today.

1 hr
This webinar reviews significant lung infections such as mucormycosis, tuberculosis, and hydatidosis. Our expert panel of speakers from the United States and Latin America will discuss controversial topics on these three diseases, state-of-the-art management, and different options in surgical approach.
Date
Duration
1 hr. 30 min.
This webinar reviews significant lung infections such as mucormycosis, tuberculosis, and hydatidosis. Our expert panel of speakers from the United States and Latin America will discuss controversial topics on these three diseases, state-of-the-art management, and different options in surgical approach.
Date
Duration
1 hr. 2 mins.

This 30-minute session expands on the STS Roadmap to Mobile Lung Cancer Screenings and examines the intricacies of mobile cancer screening units and how they operate. The event is open to all interested in creating or expanding a mobile cancer screening initiative at their institution.
 

Moderator 

Elliot L. Servais, MD
Lahey Hospital & Medical Center
Burlington, MA

 

Date
Duration
31 mins.

Don’t miss the latest Thinking Thoracic episode as host Erin Gillaspie, MD, is joined by Stephanie Worrell, MD, associate professor, University of Arizona, and thoracic surgeon, Banner Health, for a lively and insightful post-ASCO discussion. Together, they unpack the significance of the CheckMate 577 and Matterhorn trials, and explore what these groundbreaking studies mean for the future of esophageal and gastroesophageal junction cancer care.

Tune in to hear their take on:

45 min.
A multidisciplinary approach to lung cancer staging and diagnosis from medical oncology, pulmonology, and cardiothoracic surgery perspectives
Date
Duration
1 hr. 3 mins.